Exploring Treatment Options for Resistant Hypertension

This chapter explores the comparison between ameloride and mineralocorticoid inhibitors like spironolactone in the treatment of resistant hypertension. It highlights recent findings on their similar efficacy and offers clinical insights into the benefits of using ameloride, particularly for certain patient profiles.